IDEXX Laboratories, Inc. is a worldwide leader in the development and commercialization of innovative, technology-based products and services for animal health. The Company's largest business is focused on companion animal health, combining biotechnology, medical device technology and information technology to aid veterinarians in providing better medicine while building successful practices. IDEXX Laboratories is also focused on employing innovative technologies to monitor production animal health and the safety and quality of drinking water and milk. Headquartered in Westbrook, Maine, the Company employs more than 2,400 people and offers products to customers in more than 100 countries.

IDEXX's Production Animal Services business has revolutionized the diagnostic tools and information available to monitor the health of herd and flock animals around the world. Every day, hundreds of laboratories and clinics rely on IDEXX instrumentation, microtiter well assay kits, software and instrumentation for accurate assessment of infectious diseases in poultry, cattle, swine and horses. Since its beginnings in 1984, IDEXX has emerged as a worldwide leader in production animal diagnostics, dedicating itself to working with international veterinarians and researchers to provide the world's most advanced products.

The IDEXX HerdChek® Chronic Wasting Disease (CWD) Antigen Test is the first in a new line of postmortem transmissible spongiform encephalopathy (TSE) tests; and has received USDA approval for postmortem testing of CWD in white-tailed deer and mule deer. This test offers reliable and accurate results in under 3.5 hours, with less than one hour hands-on time. IDEXX anticipates submitting to the USDA additional claims for North American elk.

IDEXX has also received USDA approval for its bovine spongiform encephalopathy (BSE) test, and plans to gain an approval for scrapie test in sheep. In compliance with USDA regulations all TSE tests (i.e., CWD, Scrapie and BSE) must be performed in USDA-approved laboratories.